Filing Details

Accession Number:
0001093557-15-000327
Form Type:
4
Zero Holdings:
No
Publication Time:
2015-09-21 18:15:20
Reporting Period:
2015-09-18
Filing Date:
2015-09-21
Accepted Time:
2015-09-21 18:15:20
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1093557 Dexcom Inc DXCM Surgical & Medical Instruments & Apparatus (3841) 330857544
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1408993 Jess Roper 6340 Sequence Drive
San Diego CA 92121
Svp, Cfo No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Disposition 2015-09-18 1,000 $101.35 99,424 No 4 S Direct
Common Stock Acquisiton 2015-09-18 6,000 $9.80 105,424 No 4 M Direct
Common Stock Disposition 2015-09-18 6,000 $101.20 99,424 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 S Direct
No 4 M Direct
No 4 S Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Non-Qualified Stock Option (right to buy) Disposition 2015-09-18 6,000 $101.20 6,000 $9.80
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
11,990 2011-03-12 2020-03-12 No 4 M Direct
Footnotes
  1. On November 17, 2014, Mr. Roper adopted a 10b5-1 Plan. This 10b5-1 Plan allows the orderly disposition of shares owned by Mr. Roper. The shares set forth above were sold pursuant to the 10b5-1 Plan.
  2. This transaction was executed in multiple trades at prices ranging from $100.01 to $102.66. The price above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transactions were effected.
  3. Included in this number are 60,000 unvested restricted stock units, 40,000 of which were granted on March 8, 2015 and shall vest through March 8, 2018, 15,000 of which were granted on March 8, 2014 and shall vest through March 8, 2017 and 5,000 of which were granted on March 11, 2013 and shall vest through March 11, 2016.
  4. This transaction was executed in multiple trades at prices ranging from $99.93 to $102.66. The price above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transactions were effected.